Evidence map›Paper›PMID 31996597›Full record

ArticleAIDS (London, England)2020

In-vivo use of SIVmac239 with a reversing stop codon in the SIV nef gene.

Francois Villinger

Open access · greenAbstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in AIDS (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Early treatment with anti-αFrontiers in immunology · 2022
    Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Francois VillingerNew Iberia Research Center, University of Louisiana at Lafayette, New Iberia, Lousiana, USA.
University of Louisiana at Lafayette · US

Funding

PD-1 modulation of SIV specific CD4 and CD8 T cell responsesR01AI078775 · NIAID · EMORY UNIVERSITY · PI VILLINGER, FRANCOIS J · 2009 to 2012
$2.3M
NIAID NIH HHS R01 AI078775
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Coronary Artery DiseaseHIV InfectionsSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusAngiographyAnimalsCodon, TerminatorGenes, nefHumansnef Gene Products, Human Immunodeficiency VirusTomographyCodon, Terminatornef Gene Products, Human Immunodeficiency Virusnef protein, Human immunodeficiency virus 1nef protein, Human immunodeficiency virus 2

Identifiers

PMID31996597
PMCPMC7061280
OpenAlexW3004226614

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.